An AI diagnostics healthtech startup raising a seed round. Client name withheld under confidentiality.
A clinically complex product — AI-assisted diagnostic tooling — going in front of generalist seed investors who would not have a medical background and would not read a technical explanation.
The problem with most healthtech pitch decks is that founders explain the science. Investors are not buying the science. They are buying the adoption path.
The deck opened with the technology. Market evidence and the regulatory pathway sat on slides 11 and 14.
Moved clinical demand and the regulatory roadmap forward, ahead of the technology.
Reduced the clinical case to a few figures a non-specialist could hold in mind.
Turned the regulatory pathway into a visual milestone sequence.
Reframed the product from “an AI diagnostic tool” to “faster diagnosis, same accuracy.”
$500K+ raised. The reframe gave generalist investors something they could actually evaluate without a medical degree.
Outcome as reported by the client. Slides are not shown because the deck is confidential.
If your product is technical — medical, deep-tech, AI or climate — the slide order matters more than the visuals. Lead with the problem investors already understand and the path to adoption; explain the technology once they want to know how it works.
Related: Startup pitch deck design → · Investor pitch deck design →
Send your current deck — we'll show you where the argument loses investors and give you a fixed quote.